Search - tctmd.com

Displaying 201 - 212 of 212

Sort: Relevancy | Date

News Daily News

Se Publica el TARGET-CABG: El Período de Espera al CABG depende de la Prueba de la Función Plaquetaria

Yael L. Maxwell

March 15, 2012

Platelet Function Measurement-Based Strategy to Reduce Bleeding and Waiting Time in Clopidogrel-Treated Patients Undergoing CABG

Presentation

Platelet Function Measurement-Based Strategy to Reduce Bleeding and Waiting Time in Clopidogrel-Treated Patients Undergoing CABG

Presenter: E. Mahla

March 13, 2012

Estrategia basada en Medir la Función Plaquetaria para Reducir las Hemorragias en el Tiempo de Espera en Pacientes Tratados con Clopidogrel que se someten a un CABG

Presentation

Estrategia basada en Medir la Función Plaquetaria para Reducir las Hemorragias en el Tiempo de Espera en Pacientes Tratados con Clopidogrel que se someten a un CABG

Presenter: E. Mahla

March 13, 2012

News Daily News

TCTMD’s Top 10 Most Popular News Stories From 2011

March 08, 2012

News Daily News

Los 10 Artículos Más Populares de TCTMD de 2011

March 08, 2012

News Daily News

Details on Clopidogrel Discontinuation Remain Elusive, Unclear

August 05, 2011

News Daily News

Meta-analysis Demonstrates Mixed Evidence on CABG in ACS Patients Taking Clopidogrel

May 27, 2011

News Daily News

Late Aspirin Use Before CABG Does Not Increase Ischemic Events

February 02, 2011

News Daily News

More Than 1 in 10 Patients Discontinue Antiplatelet Therapy Early

January 24, 2011

News Daily News

PLATO CABG Cohort: Ticagrelor Cuts Total and CV Mortality in Half

January 03, 2011

News Daily News

TCTMD’s Top 10 Most Popular News Stories for 2010

January 02, 2011

Optimizing Outcomes During and After PCI: From Intravenous to Oral Platelet Inhibition

CME

Optimizing Outcomes During and After PCI: From Intravenous to Oral Platelet Inhibition

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.